🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

TB Science abstract submission is now open! The Union Conference #tbscience Please share widely! conf2023.theunion.org/tb-science/?ut…

thelancet.com/journals/lanhi… RADIANT-TB trial today in Lancet HIV. Khayelitsha 🇿🇦. Evaluated dolutegravir dosing on TB treatment. 83% VL suppression at week 24 in both 50mg bd and in 50mg daily arms. Limitations: phase 2, sample size 108. Caveat: Participants on 1st line ART only.

#NationalScienceStars We are incredibly proud to have three #MBHG scientists recognised as leaders in their field ranking in the Top 5 nationally for their respective categories 🌟 #blessedwiththebest #TopSAscientists #Immunology #microbiology #worldclass

Our IJTLD paper describes thesmoked drug use prevalence and impact on TB disease burden on presentation. PWSD have higher bacterial burden at diagnosis, check out our findings and implications for community health screening. 👇pubmed.ncbi.nlm.nih.gov/37231597/

Please come join us for this exciting project, looking for postdoctoral fellow to be based in Cape Town at Stellenbosch. Please share. CDC TB RESIST-TB LSHTM TB Centre McGill TB Centre BU_TIARA Maha Farhat

An international collaboration between Harvard Medical School and TB Genomics led by Dr Brendon Mann. Not possible without Karen R. Jacobson, MD, MPH and support from the South African NHLS!

🗣️📢We are seeking a postdoctoral research fellow opportunity at our group TB Genomics to work in collaboration with Maha Farhat, Karen R. Jacobson, MD, MPH and Dr Tara Carney from SAMRC. More info here: linkedin.com/posts/tbgenomi…

Important to support Israel in this terrible time of attack.

Work do-led by Karen R. Jacobson, MD, MPH TB Genomics, and not possible without Shandukani Mulaudzi #teamscience

Great job Brendon at presenting your work from our projects, exciting to see you continue to move this forward, great summary. In a TB endemic setting, we see many mixed infections. More to learn. Maha Farhat

Congratulations to fellows that matched today!!! However, yikes for our field- ID down to 67.3% of filled positions. Heme/Onc and Pulm/Crit Care at 99.3% and 98.5%, for example. nrmp.org/wp-content/upl…

Brilliant!

Excited to support Karen R. Jacobson, MD, MPH for The Union NAR secretary/treasurer. Easily one of the most inspiring people I know, Karen is committed to ending TB through science, discovery, and compassion. Please vote!! BU_TIARA Megan Murray Meredith Brooks, PhD, MPH @lfwhite14

Proud to share our work out now in nature nature.com/articles/s4158…! In an amazing collaboration w/ Liz Campbell & Maddie Delbeau Darst-Campbell Lab we identify the/a source of the fitness cost of rifampicin resistance (RifR) in Mtb and how some compensatory mutations rescue the cost!

Our study evaluating the challenges of pan-genome analysis is now live on BioRxiv! biorxiv.org/cgi/content/sh… (1/17)

“Journal remained all but silent regarding the deeply antisemitic and racist motives of Nazi science and medicine and the threat to the “ideals” of civilization, as Albert Einstein put it in an open letter to the Prussian Academy of Sciences” nejm.org/doi/full/10.10…

🚨 Call for papers 🚨 I'm guest editor for a special collection BMC Global and Public Health called "Evolving implementation science concepts and methods in low- and middle-income countries." biomedcentral.com/collections/ISC Please share with your networks and submit, submit, submit!